We combine a deep scientific understanding of disease biology with our innovative technology platforms to optimize the therapeutic potential of drug candidates.
We focus on targets supported by evidence from breakthrough science including both human genetics and pharmacology, while addressing the pathological mechanism to achieve the intended treatment benefit.
Investigational Therapies
Our investigational therapies target foundation biological processes, so we can explore their full therapeutic potential across a broad range of serious CNS indications.
Our discovery engine is powered by a set of interconnected and fit-for-purpose platform technologies that provide the ability to efficiently identify and evaluate novel drug candidates from less explored realms of chemistry and biology.
